UBS AG - ACURA PHARMACEUTICALS INC ownership

ACURA PHARMACEUTICALS INC's ticker is ACUR and the CUSIP is 00509L703. A total of 34 filers reported holding ACURA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 2.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS AG ownership history of ACURA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2014$12,000
+140.0%
15,713
+249.2%
0.00%
Q2 2014$5,000
-73.7%
4,500
-65.4%
0.00%
Q1 2014$19,000
-74.3%
13,000
-70.7%
0.00%
Q4 2013$74,000
+335.3%
44,367
+381.2%
0.00%
Q3 2013$17,000
+54.5%
9,220
+61.7%
0.00%
Q2 2013$11,0005,7010.00%
Other shareholders
ACURA PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 10,294,886$16,396,0008.24%
FAS Wealth Partners, Inc. 91,983$154,0000.09%
CORTLAND ASSOCIATES INC/MO 39,050$65,0000.01%
Tower Research Capital LLC (TRC) 37,812$63,0000.01%
Mariner, LLC 52,018$87,0000.01%
OPPENHEIMER & CO INC 55,000$92,0000.00%
Weiss Multi-Strategy Advisers LLC 75,000$125,0000.00%
COMMERCE BANK 89,400$150,0000.00%
Spark Investment Management LLC 12,300$20,0000.00%
Hodges Capital Management Inc. 28,950$48,0000.00%
View complete list of ACURA PHARMACEUTICALS INC shareholders